◆ TICKERBASEOpen interactive view →
◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocksM › MPT

Medical Properties Trust, Inc. (MPT) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

REAL ESTATE · REIT - HEALTHCARE FACILITIES · DATA UPDATED 2026-09-05

Medical Properties Trust, Inc. (MPT) operates in the REIT - HEALTHCARE FACILITIES industry and is headquartered in Birmingham, United States with about 121 employees. Its market capitalization is roughly $2 billion. In the fiscal year ended 2025-12-31, MPT reported $972M in revenue and ($277M) in net income.

Medical Properties Trust, Inc. is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities.

Interactive charts & full statements → Open the MPT valuation workbench →

MPT Revenue & Earnings History — Annual Income Statement

Income statementTTM → 2026-06-302025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-31
Total Revenue$1.0B$972M$996M$872M$1.5B$1.5B$1.2B$870M$705M$541M$442M$313M$243M$198M$132M$108M$114M$107M$82M$50M$30M
Gross Profit$841M$936M$968M$830M$1.5B$1.5B$1.2B$846M$699M$538M$438M$311M$240M$197M$132M$104M$110M$103M$82M
Gross Margin %82.5%96.2%97.3%95.2%97.0%97.5%98.0%97.2%99.2%99.5%99.1%99.4%99.0%99.2%99.5%95.9%96.7%96.0%100.0%
Operating Income (EBIT)$577M$540M$387M$81M$1.0B$1.0B$750M$486M$342M$263M$143M$154M$130M$70M$42M$68M$61M$56M$34M$18M
Operating Margin %56.6%55.5%38.9%9.3%65.0%67.2%86.2%68.9%63.1%59.6%45.7%63.3%65.5%53.0%39.1%59.2%56.9%68.2%66.5%59.9%
Net Income($30M)($277M)($2.4B)($556M)$903M$656M$431M$375M$290M$225M$140M$51M$97M$90M$27M$23M$36M$33M$41M$30M$20M
Net Margin %-3.0%-28.5%-242.1%-63.8%58.5%42.5%34.5%43.0%41.1%41.6%31.6%16.2%40.0%45.4%20.1%21.2%31.9%30.5%50.4%59.8%64.5%
EBITDA$1.1B$546M($1.5B)$340M$1.7B$1.5B$1.1B$754M$647M$476M$334M$204M$196M$167M$92M$63M$94M$88M$69M$42M$23M
Earnings Per Share (EPS)$-0.05$-0.46$-4.02$-0.93$1.51$1.11$0.81$0.87$0.83$0.86$0.64$0.30$0.64$0.68$0.24$0.23$0.47$0.53$0.86$0.76$0.61
Shares Outstanding (M)598M601M600M599M599M590M530M428M350M261M218M171M153M132M111M101M78M62M48M40M32M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

MPT Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
Total Revenue$259M$252M$270M$238M$240M$224M$235M$226M
Gross Profit$109M$242M$261M$229M$229M$217M$225M$221M
Gross Margin %42.1%96.1%96.5%96.2%95.5%96.9%95.8%97.8%
Operating Income (EBIT)$144M$140M$169M$124M$137M$110M$197M($21M)
Operating Margin %55.5%55.6%62.5%52.1%56.8%49.3%83.7%-9.2%
Net Income($3M)$33M$17M($78M)($98M)($118M)($413M)($801M)
Net Margin %-1.0%13.0%6.4%-32.7%-40.9%-52.8%-175.5%-354.8%
EBITDA$214M$207M$495M$135M$110M$73M$177M($479M)
Earnings Per Share (EPS)$-0.00$0.05$0.03$-0.13$-0.16$-0.20$-0.69$-1.33
Shares Outstanding (M)598M598M601M601M601M601M600M600M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

MPT Free Cash Flow History

Cash flowTTM → 2026-06-302025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-31
Cash from Operations (CFO)$227M$231M$245M$506M$739M$812M$618M$494M$363M$265M$207M$150M$141M$105M$79M$61M$63M$70M$37M$42M$24M
Capital Expenditures (CapEx)$393M$222M$185M$350M$1.5B$66M$4.3B$4.9B$2.2B$28M$2.2B$0M$0M$0M$270M$144M$0M$431M$213M$236M$98M
Free Cash Flow (FCF)($166M)$9M$60M$156M($801M)$746M($3.7B)($4.4B)($1.9B)$237M($2.0B)$150M$141M$105M($190M)($84M)$62M($361M)($176M)($194M)($74M)
FCF Margin %-16.3%0.9%6.0%17.9%-51.9%48.3%-293.6%-501.5%-267.3%43.8%-455.3%48.1%58.1%53.1%-143.8%-77.6%54.7%-337.0%-215.4%-383.8%-241.4%
Dividends Paid$193M$321M$615M$699M$643M$568M$412M$327M$218M$183M$144M$120M$104M$90M$77M$62M$65M$53M$36M$17M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

MPT Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
Cash from Operations (CFO)$62M($14M)$160M$19M$52M$0M$77M$59M
Capital Expenditures (CapEx)$0M$0M$222M$171M$143M$65M$0M$0M
Free Cash Flow (FCF)$62M($14M)($62M)($152M)($91M)($65M)$77M$59M
FCF Margin %24.1%-5.7%-22.9%-64.1%-38.0%-29.0%32.6%26.2%
Dividends Paid$55M$48M$48M$48M$48M$48M$90M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

MPT Balance Sheet History

Balance sheet2026-06-302025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-31
Total Assets$14.7B$15.0B$14.3B$18.3B$19.7B$20.5B$16.8B$14.5B$9.0B$6.4B$5.6B$3.7B$2.9B$2.2B$1.6B$1.3B$1.3B$1.3B$1.1B$745M$501M
Cash & Cash Equivalents$397M$541M$332M$250M$236M$459M$550M$1.5B$171M$83M$196M$145M$46M$37M$103M$98M$15M$12M$94M$4M$59M
Total Liabilities$10.2B$10.4B$9.5B$10.7B$11.1B$12.1B$9.5B$7.4B$5.2B$3.2B$3.5B$2.4B$1.6B$1.1B$793M$449M$638M$693M$538M$400M$143M
Total Debt (Short + Long-Term)$1.3B$10.3B$8.8B$10.1B$10.3B$9.7B$51M$6M$0M$0M$125M$593M$0M$0M$40M$370M$0M$0M$0M$0M$0M
Total Shareholders' Equity$4.5B$4.6B$4.8B$7.6B$8.6B$8.4B$7.3B$7.0B$3.8B$3.2B$2.1B$1.4B$1.3B$1.1B$829M$899M$671M$618M$513M$344M$356M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive MPT viewer.

Other Companies in REIT - HEALTHCARE FACILITIES

← MPSLTDAll “M” companiesMPV →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.